MEI Pharma, Inc. Annual Operating Income (Loss) in USD from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
MEI Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2024.
  • MEI Pharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$19M, a 71.3% decline year-over-year.
  • MEI Pharma, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $14.5M.
  • MEI Pharma, Inc. annual Operating Income (Loss) for 2024 was $14.5M.
  • MEI Pharma, Inc. annual Operating Income (Loss) for 2023 was -$36.8M, a 51.3% increase from 2022.
  • MEI Pharma, Inc. annual Operating Income (Loss) for 2022 was -$75.5M, a 24.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $14.5M +$51.3M Jul 1, 2023 Jun 30, 2024 10-K 2024-09-19
2023 -$36.8M +$38.7M +51.3% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-19
2022 -$75.5M -$15.1M -24.9% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-26
2021 -$60.4M -$34.7M -135% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-08
2020 -$25.7M +$20.5M +44.4% Jul 1, 2019 Jun 30, 2020 10-K 2022-09-08
2019 -$46.2M -$17.7M -61.8% Jul 1, 2018 Jun 30, 2019 10-K/A 2022-05-23
2018 -$28.6M -$31M -1299% Jul 1, 2017 Jun 30, 2018 10-K 2020-09-09
2017 $2.38M +$23.4M Jul 1, 2016 Jun 30, 2017 10-K 2019-08-28
2016 -$21M +$11.8M +35.9% Jul 1, 2015 Jun 30, 2016 10-K 2018-08-30
2015 -$32.8M -$5.54M -20.4% Jul 1, 2014 Jun 30, 2015 10-K 2017-09-05
2014 -$27.2M -$16M -143% Jul 1, 2013 Jun 30, 2014 10-K 2016-09-06
2013 -$11.2M -$2.83M -33.7% Jul 1, 2012 Jun 30, 2013 10-K 2015-09-02
2012 -$8.39M -$1.94M -30.1% Jul 1, 2011 Jun 30, 2012 10-K 2014-09-09
2011 -$6.45M Jul 1, 2010 Jun 30, 2011 10-K 2012-09-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.